Addressing Low Vision due to Severe Peripheral Field Loss: Development and Validation of a Patient-Centered Outcome Measure
解决因严重周边视野丧失导致的低视力问题:以患者为中心的结果测量的开发和验证
基本信息
- 批准号:9294683
- 负责人:
- 金额:$ 22.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-01 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:Activities of Daily LivingAddressAffectAreaAttenuatedAwarenessBehaviorBlindnessCaregiversCaringChronicClinicalClinical ResearchClinical TrialsCognitiveConsensusDataDevelopmentDorsalEffectivenessEnsureEvaluationFocus GroupsFutureGlaucomaGoalsHispanicsImpairmentIndividualInstitutesInterventionInterviewJournalsKnowledgeLifeMeasurementMeasuresMentorsMentorshipMethodologyMethodsMichiganMissionModelingMotion PerceptionMotorNational Eye InstituteOphthalmologistOphthalmologyOutcomeOutcome MeasureOutcomes ResearchPathway interactionsPatient Outcomes AssessmentsPatient-Focused OutcomesPatientsPeripheralPopulationPopulation InterventionPrevalencePrincipal Component AnalysisProviderPsychometricsPublic HealthQuality of lifeRandomized Controlled TrialsRehabilitation therapyResearchResearch DesignResearch PersonnelResearch PriorityRetinal DegenerationReview LiteratureSelf-DirectionSelf-Help DevicesStreamSurveysTestingTrainingUnited StatesUniversity resourcesValidationValidity and ReliabilityVisionVision DisordersVision TestsVisual AcuityVisual FieldsVisual impairmentWorkblindcareercareer developmentcompare effectivenessdesignfunctional disabilityimprovedimproved functioninginformation processinginsightinstrumentpatient orientedprogramsrehabilitation strategyresponseskillsspatial visionsystematic reviewtheoriesvision rehabilitationvisual processing
项目摘要
Abstract
The burden of blindness and visual impairment in the United States is expected to double between 2015 and
2050 to 8.96 million people. Blacks, Hispanics and older individuals will be disproportionally affected, further
accentuating the disparate impact of vision disorders. Although low vision rehabilitation (LVR) has been shown
to improve the functioning of patients, considerable opportunities remain to better understand and overcome
functional limitations due to low vision. Specifically, the effectiveness of LVR for patients with peripheral field
loss (PFL) has not been well-studied, though 15-20% of patients presenting for LVR have glaucoma or a retinal
degeneration, two important causes of PFL. In order to evaluate and compare interventions for this population,
a highly relevant measure of functioning is needed. The proposed project will address this through the
development and validation of a patient-reported outcome measure, the Low Vision Severely Constricted
Peripheral Eyesight (LV-SCOPE) Assessment. In Aim 1 of this proposal, focus groups with patients, caretakers
and vision providers will identify the impairments and LVR goals associated with severe PFL. Since PFL often
exists in combination with visual acuity loss, patients with PFL and a range of visual acuities will be included.
We anticipate that PFL will preferentially impact known functions of the dorsal visual processing stream, as this
pathway depends on peripheral vision for spatial awareness and motor behavior. In Aim 2, focus group data
will guide the selection of survey items for the outcome measure. In Aim 3, psychometric evaluations will test
the validity, reliability and precision of the LV-SCOPE. Once validated, the LV-SCOPE may be an optimal
outcome measure to evaluate and identify targeted LVR strategies for patients with PFL, a sizable
understudied population. This project directly addresses the National Eye Institute's low vision priority research
area “to create and validate vision tests relevant for the tasks of daily living.” Dr. Ehrlich's long-term career goal
is to improve the vision-dependent functioning of patients with low vision. He will achieve this through
coursework, mentorship and research to improve the measurement of functional impairment and facilitate the
evaluation of targeted LVR strategies. The applicant's training plan is a natural progression from his
background in ophthalmology, clinical research and public health. He will acquire knowledge and expertise in
outcome measure development and psychometrics, low vision and rehabilitation, mixed-methods analyses and
clinical trials. Dr. Ehrlich has devised a plan of pertinent coursework, individualized mentorship, and directed
self-study to achieve his training and research goals. Dr. Ehrlich's career development will benefit from the vast
resources of the University of Michigan and the support of his mentors, including Drs. Noelle Carlozzi, Paul
Lee, Robert Massof and Joan Stelmack. This proposal demonstrates Dr. Ehrlich's commitment to gaining the
necessary skills to become an independent investigator and to addressing a pressing public health need.
摘要
美国失明和视力障碍的负担预计将在2015年至2019年期间翻一番。
2050至896万人。黑人、西班牙裔和老年人将受到更大的影响,
强调视觉障碍的不同影响。虽然低视力康复(LVR)已被证明
为了改善患者的功能,还有相当多的机会可以更好地理解和克服
由于视力低下导致的功能限制。具体而言,LVR对外周野患者的有效性
尽管15 - 20%的LVR患者患有青光眼或视网膜脱离,但LVR的PFL尚未得到充分研究。
变性,PFL的两个重要原因。为了评估和比较针对该人群的干预措施,
需要一个高度相关的运作措施。拟议项目将通过以下方式解决这一问题:
开发和验证患者报告的结局指标,低视力严重收缩
周边视力(LV-SCOPE)评估。在本提案的目标1中,
视力提供者将确定与严重PFL相关的损害和LVR目标。由于PFL经常
合并视力丧失,将纳入PFL和一系列视力的患者。
我们预计,PFL将优先影响背侧视觉处理流的已知功能,因为这
路径依赖于周边视觉的空间意识和运动行为。在目标2中,焦点小组数据
将指导成果计量的调查项目的选择。在目标3中,心理测量评估将测试
LV-SCOPE的效度、信度和精密度。一旦验证,LV-SCOPE可能是最佳的
一项评估和确定PFL患者的靶向LVR策略的结果指标,
被忽视的人群这个项目直接解决了国家眼科研究所的低视力优先研究
创建和验证与日常生活任务相关的视力测试。埃利希博士的长期职业目标
是改善低视力患者的视觉依赖功能。他将通过
课程,指导和研究,以改善功能障碍的测量和促进
评估有针对性的LVR策略。申请人的培训计划是从他的
具有眼科学、临床研究和公共卫生背景。他将获得知识和专业知识,
结果测量开发和心理测量、低视力和康复、混合方法分析和
临床试验埃利希设计了一个相关的课程计划,个性化的指导,并指导
自学,以实现他的培训和研究目标。埃利希博士的职业发展将受益于广大
密歇根大学的资源和他的导师,包括博士的支持。
作者声明:Robert Massof and Joan Stelmack.该提案表明了埃利希博士致力于获得
成为独立调查员和解决紧迫的公共卫生需求所需的必要技能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joshua Robert Ehrlich其他文献
Joshua Robert Ehrlich的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joshua Robert Ehrlich', 18)}}的其他基金
Vision Impairment in the National Health and Aging Trends Study: Epidemiology, Social Determinants of Health, and Adverse Late Life Outcomes
国家健康和老龄化趋势研究中的视力障碍:流行病学、健康的社会决定因素和不良的晚年结局
- 批准号:
10730418 - 财政年份:2023
- 资助金额:
$ 22.45万 - 项目类别:
Longitudinal Study of Health and Ageing in Kenya (LOSHAK)
肯尼亚健康与老龄化纵向研究 (LOSHAK)
- 批准号:
10427945 - 财政年份:2022
- 资助金额:
$ 22.45万 - 项目类别:
Building Non-Communicable Eye Disease Research Capacity in India
在印度建设非传染性眼病研究能力
- 批准号:
10676301 - 财政年份:2021
- 资助金额:
$ 22.45万 - 项目类别:
Addressing Low Vision due to Severe Peripheral Field Loss: Development and Validation of a Patient-Centered Outcome Measure
解决因严重周边视野丧失导致的低视力问题:以患者为中心的结果测量的开发和验证
- 批准号:
10237987 - 财政年份:2017
- 资助金额:
$ 22.45万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 22.45万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 22.45万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 22.45万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 22.45万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 22.45万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 22.45万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 22.45万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 22.45万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 22.45万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 22.45万 - 项目类别:
Research Grant














{{item.name}}会员




